Clinical Trials Logo

Iron Overload clinical trials

View clinical trials related to Iron Overload.

Filter by:

NCT ID: NCT06215287 Not yet recruiting - Clinical trials for Chronic Iron Overload

Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials

Start date: March 29, 2024
Phase:
Study type: Observational

The objective of this survey is to assess the knowledge of HCPs in relation to the recommended posology and biological monitoring for Exjade, based on the current locally valid Exjade educational materials (including the physician's reference checklist)

NCT ID: NCT06146608 Recruiting - Iron Overload Clinical Trials

Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption

FeMicrobiome
Start date: January 15, 2023
Phase:
Study type: Observational

The FeMicrobiome study will evaluate gut microbiome features and their relationships with dietary iron absorption in healthy adults. The investigators hypothesize that (1) the gut microbiota can be shaped by the heme and non-heme Fe content of the diet and that (2) this will influence individual variation in dietary Fe absorption.

NCT ID: NCT06137079 Recruiting - Iron Overload Clinical Trials

"Iron Overload and Endocrinological Diseases"

Start date: June 20, 2013
Phase:
Study type: Observational

Patients with hemochromatosis or Thalassemia develop progressive tissue and organs damages secondary to iron overload. Iron overload can result both from transfusional hemosiderosis and excess gastrointestinal iron absorption. Iron deposition in the heart, liver, and multiple endocrine glands results in severe damage to these organs, with variable degrees of endocrine and organ failure. Although patients with iron overload often present endocrine disorders, the pathogenetic mechanisms underlying endocrinopathies are not completely clear. In particular it is not elucidated if the spectrum of endocrinopathies could change with advancing age. All endocrinological comorbidities can develop from a primary damage of the target gland, from pituitary secondary failure or from both. The aim of this study is to investigate the prevalence of endocrinological diseases in adult patients with iron overload due to β-thalassemia or hemochromatosis and their impact on well-being and quality of life. The study design is a prospective cross-sectional clinical study. All subjects enrolled will be evaluated for the endocrine diseases. The study protocol will include data collection from family and patients' history of diseases, physical examination, hormonal assessment for all endocrine axes and instrumental examinations. The results will provide evidence on the prevalence of endocrine diseases in patients with iron overload and will add information to characterize the type and the degree of endocrine deficiencies, and on the pathogenic mechanisms involved, in order to individualize diagnostic and therapeutic approaches.

NCT ID: NCT05777733 Not yet recruiting - Thalassemia Major Clinical Trials

NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major

Start date: March 23, 2024
Phase: Phase 1
Study type: Interventional

The effect of N_acetylcystein as an antioxidant on iron overload and frequency of blood transfusion in β-thalassemia major patients at Assiut Childern Hospital University And its cosubmitted for partial fulfillment of master degree in Pediatrics

NCT ID: NCT05586932 Not yet recruiting - Clinical trials for Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System

Oxidative Stress and Iron Overload in Patient With Abnormal Haemoglobinopathy

Start date: December 1, 2022
Phase:
Study type: Observational

The effects of iron overload and oxidative stress and dyslipidemia on glucose level and thyroid function in patients with abnormal hemoglobinopathy. 2- Evaluation of MDA level as a marker of oxidative stress.

NCT ID: NCT05440487 Completed - Clinical trials for Chronic Iron Overload

Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

EXCALIBUR
Start date: September 15, 2015
Phase:
Study type: Observational

This is a prospective, multicenter, non-interventional study. Findings are analyzed using epidemiological methods.

NCT ID: NCT05355766 Recruiting - Thalassemia Clinical Trials

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

Start date: June 2, 2022
Phase: Phase 2
Study type: Interventional

The safety and efficacy of CN128 is studied in thalassaemia with sever liver iron overloaded patients.

NCT ID: NCT05326503 Not yet recruiting - Thalassemia Clinical Trials

Inhibitory Effect of a Polyphenol Supplement on Dietary Iron Absorption in Adults With Thalassemia

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Genetic disorders, such as thalassemia, can lead to iron overload and severe adverse health outcomes. In iron-loading thalassemia, iron overload is due to increased iron absorption. Iron accumulates in the body organs causing widespread damage. The standard treatment is iron chelation therapy and/or periodic phlebotomy to remove iron from the body; frequency of phlebotomy or chelation therapy is dependent on how quickly body iron stores accumulate. Polyphenolic compounds are very strong inhibitors of non-heme iron absorption, as they form insoluble complexes with ferrous iron in the gastrointestinal tract that cannot be absorbed. The investigators have recently shown in European subjects with hereditary hemochromatosis (another iron-loading disorder) that our newly-developed natural polyphenol supplement (PPS) that is rich in polyphenols, when taken with iron-rich meals or with an iron-fortified drink, reduces iron absorption by ~40%. Decreasing non-heme iron absorption in adults with iron-loading thalassemia could potentially lead to an extension of the time period between phlebotomies or chelation therapies, and therefore an improved quality of life. Therefore, in this stable iron isotope study, the investigators will study the effect the natural PPS on oral iron absorption from an iron-rich test meal or iron-fortified drink in Thai adults with iron-loading thalassemia.

NCT ID: NCT05294471 Recruiting - Healthy Clinical Trials

Fully Automated High-Throughput Quantitative MRI of the Liver

Start date: October 16, 2023
Phase:
Study type: Observational

The purpose of this research is to see if a new automated magnetic resonance imaging (MRI) method will be able to improve the images taken of the liver. Participants will have either known or suspected liver disease, known or suspected iron overload syndrome, or be a healthy adult. Participants will be in the research study for one day.

NCT ID: NCT05028595 Completed - Hepatic Injury Clinical Trials

Evaluation of Hepatic Affection in Hemodialysis Patients With Iron Overload in Assiut University Hospital

Start date: January 20, 2019
Phase:
Study type: Observational

Aim of the work 1. Assessment of hepatic affection in patients with ESRD (end stage renal disease) on regular dialysis with iron indices suggesting iron overload. 2. Comparison between HCV -negative HD patients with high and normal TSAT as regard liver iron concentration(LIC) and degree of fibrosis.